Leadership change for the Institute of Translational Health Sciences
Dr. Mary “Nora” Disis, MD, principal investigator for the Institute of Translational Health Sciences (ITHS) will depart from this position, effective March 1, 2024. She will remain active in several other roles, including as Director of the UW Medicine Cancer Vaccine Institute, where she is...